ASX:PKYSoftware & ServicesApplication Software
PATHKEY.AI ORD
$0.042
Day Range
$0.042 - $0.045
52 Week Range
$0.013 - $0.071
Volume
3.39M
Avg Volume (10D)
4.42M
Market Cap
$25.50M
Price Chart
Market Statistics
Open$0.042
Previous Close$0.042
Day High$0.045
Day Low$0.042
52 Week High$0.071
52 Week Low$0.013
Valuation
Market Cap25.50M
Shares Outstanding607.08M
Price to Book29.02
Trading Activity
Volume3.39M
Value Traded147.02K
Bid$0.041 × 200,000
Ask$0.043 × 35,000
Performance
1 Day7.50%
5 Day-18.87%
13 Week104.76%
52 Week107.67%
YTD168.75%
Technical Indicators
RSI (14)53.15
50-Day SMA$0.032
200-Day SMA$0.024
Latest News
Technology
Pathkey.AI Moves to Add Semiconductor Design Platform through Chipforge Acquisition
Pathkey.AI to acquire Chipforge, expanding AI into semiconductor design; irrevocable option to buy 100% within 2 months, via 560 million Pathkey shares.
2 min read
Technology
Pathkey.AI Lands Largest Contract Yet for TrialKey Platform with Imunexus Therapeutics
Pathkey.AI lands its biggest deal yet with Imunexus for TrialKey, up to $100k (incl. $25k upfront); remainder tied to capital raises—1-year pact.
1 min read
Technology
Pathkey.AI Validates TrialKey With Strong Alignment To Clinical Outcomes
Pathkey.AI (ASX: PKY) has unveiled its first validation study of the TrialKey platform, an AI tool to predict clinical trial success. The company reported that TrialKey correctly aligned with 73% of trial outcomes across 11 clinical programs that reported results between March and July 2025. Management said the findings mark a critical step in proving […]
2 min read